Sender Co & Partners »

Amicus Therapeutics shares owned by Sender Co & Partners

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Sender Co & Partners from 13F filings

Historical chart of Sender Co & Partners investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Sender Co & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Sender Co & Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $272k 35k 7.88

More positions owned by Sender Co & Partners

Kenvue (KVUE)
Boeing Company (BA)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Kimberly-Clark Corporation (KMB)
Meta Platforms Cl A (META)
Freeport-mcmoran Call Call Option
USA Rare Earth Inc A (USAR)
Select Sector Spdr Tr State Street Hea (XLV)
Aurora Innovation Class A Com (AUR)
Amazon (AMZN)
Warby Parker Cl A Com (WRBY)
Constellation Energy (CEG)
Advisorshares Tr Pure Us Cannabis (MSOS)
Honeywell International (HON)

View all positions for Sender Co & Partners

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
Wellington Management Company
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management
Soros Fund Management

View all funds holding Amicus Therapeutics